Research programme: vanilloid prodrugs - Vitality Biopharma

Drug Profile

Research programme: vanilloid prodrugs - Vitality Biopharma

Latest Information Update: 07 Apr 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Vitality Biopharma
  • Class Analgesics
  • Mechanism of Action TRPV1 receptor modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Research Pain

Most Recent Events

  • 05 Apr 2017 Vitality Biopharma files for International patent protection for vanilloid prodrugs
  • 09 Nov 2016 Vitality files for patent protection with The Patent Cooperation Treaty (PCT) for vanniloid prodrugs
  • 24 Aug 2016 Early research in Pain in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top